Loading Events

« All Events

IEC at EADV 2020 – Vienna, Austria

October 28 @ 9:00 am - 1:00 pm CET

Novel systemic treatments for Atopic dermatitis and clinical trial design

At EADV 2020 | Wednesday, October 28, 2020 | 9:00 – 13:00 CEST

Austria Center Vienna (ACV), Bruno-Kreisky-Platz 1, Hall K | Vienna, Austria

Join the IEC at a special symposium to discuss new systemic treatments for atopic dermatitis and clinical trial design.  This symposium will take place prior to the European Academy of Dermatology and Venereology (EADV) in Vienna, Austria.

PROGRAM CHAIRS

  • Robert Bissonnette, MD, Montreal, QC, Canada
  • Diamant Thaci, MD, Lubeck, Germany
  • Thomas Bieber, MD, Bonn, Germany

AGENDA

09:00 – 09:10 – Welcome and Introduction to IEC
Emma Guttman, MD, IEC President, New York, NY, USA

09:10 – 09:20 – Program Overview
Robert Bissonnette, MD, Montreal, QC, Canada

09:20 – 09:45 – Optimizing Clinical Trial Design for AD drug development
Robert Bissonnette, MD, Montreal, QC, Canada

09:45 – 10:10 – Novel Systemic Treatments in Pediatrics and Placebo Responses in Systemic Trails
Michael Cork, MD, Sheffield, UK

10:10 – 10:35 – Monoclonal antibodies targeting Th2 receptors and cytokines (e.g. IL4R, IL-13 and IL-31)
Thomas Bieber, MD, Bonn, Germany

10:35 – 10:50 – Break

10:50 – 11:15 – Monoclonal antibodies targeting epithelial-derived protein (e.g. IL-17C, IL-33 and TSLP)
Diamant Thaci, MD, Lubeck, Germany

11:15 – 11:40 – Monoclonal antibodies with other targets (e.g. OX40, IL-22 and IL-23) and biomarkers of disease response
Emma Guttman, MD, New York, NY, USA

11:40 – 12:05 – JAK inhibitors
Eric Simpson, MD, Portland, OR, USA

12:05 – 12:30 – Other systemic treatments
Andreas Wollenberg, MD, Munich, Germany

12:30 – 12:50 – Panel Discussion and Questions
Diamant Thaci, MD, Lubeck, Germany

12:50–13:00 – Closing Comments
Thomas Bieber, MD, Bonn, Germany

 

Details

Date:
October 28
Time:
9:00 am - 1:00 pm CET
Website:
https://www.eadv.org/calendar/2020